The ultimate controlling entity of the CSL Group is CSL Limited, otherwise described as the parent company. Outlined below is the Group’s consolidated entity disclosure statement as at 30 June 2025 prepared in accordance with the Corporations Act 2001 (Cth). Unless otherwise indicated, no entities are trustees, partners or participants in joint ventures. CSL Limited Australian Australia Controlled entities (wholly owned) of CSL Limited: CSL General Employee Share Ownership Company Pty Ltd Australian Australia 100 % CSL Gene Therapy Pty Ltd Australian Australia 100 % CSL Innovation Pty Ltd Australian Australia 100 % CSL Behring (Australia) Pty Ltd Australian Australia 100 % CSL Behring (Holdings) Pty Ltd Australian Australia 100 % CSL Finance Pty Ltd Australian Australia 100 % CSL IP Investments Pty Ltd Australian Australia 100 % Seqirus (Australia) Pty Ltd Australian Australia 100 % Seqirus Holdings Australia Pty Ltd Australian Australia 100 % Seqirus Pty Ltd Australian Australia 100 % Vifor Pharma Pty Limited Australian Australia 100 % CSL Behring GmbH Foreign Austria 100 % Vifor Pharma Österreich GmbH Foreign Austria 100 % CSL Behring S.A. Foreign Argentina 100 % Laboratorios Seqirus S.A. Foreign Argentina 100 % Vifor Pharma América Latina S.A. Foreign Argentina 100 % CSL Behring NV Foreign Belgium 100 % Vifor Pharma België NV Foreign Belgium 100 % CSL Behring Comercio de Produtos Farmaceuticos Ltda Foreign Brazil 100 % Seqirus Laboratorios Do Brasil Ltda Foreign Brazil 100 % Vifor Pharma Brasil Ltda. Foreign Brazil 100 % CSL Behring Canada Inc Foreign Canada 100 % Vitaeris Inc Foreign Canada 100 % Seqirus Canada Inc Foreign Canada 100 % CSL Behring SpA Foreign Chile 100 % Guangzhou Junxin Pharmaceutical Co Ltd Foreign China 100 % CSL Behring Colombia S.A.S Foreign Colombia 100 % CSL Behring s.r.o. Foreign Czech Republic 100 % CSL Behring ApS Foreign Denmark 100 % CSL Behring S.A. Foreign France 100 % Vifor France S.A.S. Foreign France 100 % CSL Behring GmbH Foreign Germany 100 % CSL Plasma GmbH Foreign Germany 100 % CSL Behring Beteiligungs und Verwaltungs GmbH & Co KG2 Foreign Germany 100 % CSL Finance GmbH Foreign Germany 100 % CSL Behring Holdings GmbH Foreign Germany 100 % CSL Innovation GmbH Foreign Germany 100 % CSL Behring Verwaltungs GmbH Foreign Germany 100 % Seqirus GmbH Foreign Germany 100 % Entity name (all represent body corporate entities unless otherwise specified) Australian or Foreign resident Country of Incorporation and Tax Residency1 Percentage owned (%) Consolidated Entity Disclosure Statement For the Year Ended 30 June 2025 1 All entities have retained the same tax residency as their country of incorporation. 2 Entity represents a limited partnership. Consolidated Entity Disclosure Statement For the Year Ended 30 June 2025 130 Financial Report
RkJQdWJsaXNoZXIy MjE2NDg3